ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing
Beijing, ChinaThe ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing is an intensive educational symposium scheduled for March 27–28, 2026, in Beijing, China. Co-chaired by Giuseppe Curigliano and Binghe Xu, this 1.5-day course is specifically designed for experienced oncologists and oncology […]